Receipt and timing of HIV drug resistance testing in six U.S. jurisdictions

References

• Bradley, H., Hall, H. I., Wolitski, R. J., Van Handel, M. M., Stone, A. E., LaFlam, M., & Valleroy, L. A. (2014). Vital signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. Morbidity and Mortality Weekly Report, 63(47), 1113–1117.
   PubMed Web of Science ®Google Scholar
• Buchacz, K., Young, B., Palella, F. J. , Jr, Armon, C., Brooks, J. T., & HIV Outpatient Study (HOPS) investigators. (2015). Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV outpatient study, 1999–2011. Journal of Antimicrobial Chemotherapy, 70(8), 2337–2346. doi:10.1093/jac/dkv120 doi: 10.1093/jac/dkv120
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2015). Monitoring selected national HIV prevention and care objectives by using HIV surveillance dataUnited States and 6 dependent areas, 2014. HIV Surveillance Supplemental Report 2016; 21(4). http://www.cdc.gov/hiv/library/reports/surveillance.
   Google Scholar
• Centers for Disease Control and Prevention. (2016). Diagnoses of HIV infection in the United States and dependent areas, 2014. HIV Surveillance Report, 2014, 26), http://www.cdc.gov/hiv/library/reports/surveillance/
   Google Scholar
• Conrad, C., Bradley, H. M., Broz, D., Buddha, S., Chapman, E. L., Galang, R. R. Duwve, J. M. (2015). Community outbreak of HIV infection linked to injection drug use of Oxymorphone–Indiana, 2015. Morbidity and Mortality Weekly Report, 64(16), 443–444.
   PubMed Web of Science ®Google Scholar
• Deeks, S. G., Gange, S. J., Kitahata, M. M., Saag, M. S., Justice, A. C., Hogg, R. S., … North American AIDS Cohort Collaboration on Research and Design. (2009). Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clinical Infectious Diseases, 49(10), 1582–1590. doi:10.1086/644768 doi: 10.1086/644768
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
   Google Scholar
• Gill, V. S., Lima, V. D., Zhang, W., Wynhoven, B., Yip, B., Hogg, R. S., … Harrigan, P. R. (2010). Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clinical Infectious Diseases, 50(1), 98–105. doi:10.1086/648729
   PubMed Web of Science ®Google Scholar
• Harrison, K. M., Kajese, T., Hall, H. I., & Song, R. (2008). Risk factor redistribution of the national HIV/AIDS surveillance data: An alternative approach. Public Health Representative, 123(5), 618–627. doi: 10.1177/003335490812300512
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. (2005). Public financing and delivery of HIV/AIDS care: Securing the legacy of Ryan White. Washington, DC: The National Academies Press.
   Google Scholar
• Johnson, J. A., Li, J. F., Wei, X., Lipscomb, J., Irlbeck, D., Craig, C., … Heneine, W. (2008). Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy. PLoS Medicine, 5(7), e158. doi:10.1371/journal.pmed.0050158
   PubMed Web of Science ®Google Scholar
• Kantor, R., Smeaton, L., Vardhanabhuti, S., Hudelson, S. E., Wallis, C. L., Tripathy, S., … AIDS Clinical Trial Group (ACTG) A5175 Study Team. (2015). Pretreatment HIV drug resistance and HIV-1 subtype C are independently associated with virologic failure: Results from the multinational PEARLS (ACTG A5175) clinical trial. Clinical Infectious Diseases, 60(10), 1541–1549. doi:10.1093/cid/civ102 doi: 10.1093/cid/civ102
   PubMed Web of Science ®Google Scholar
• Little, S. J., Holte, S., Routy, J. P., Daar, E. S., Markowitz, M., Collier, A. C., … Richman, D. D. (2002). Antiretroviral-drug resistance among patients recently infected with HIV. New England Journal of Medicine, 347(6), 385–394. doi:10.1056/NEJMoa013552
   PubMed Web of Science ®Google Scholar
• Lu, N., Samuels, M. E., Kletke, P. R., & Whitler, E. T. (2010). Rural-urban differences in health insurance coverage and patterns among working-age adults in Kentucky. The Journal of Rural Health, 26(2), 129–138. doi:10.1111/j.1748-0361.2010.00274.x
   PubMed Web of Science ®Google Scholar
• Moneyham, L., McLeod, J., Boehme, A., Wright, L., Mugavero, M., Seal, P., … Kempf, M. C. (2010). Perceived barriers to HIV care among HIV-infected women in the deep south. Journal of the Association of Nurses in AIDS Care, 21(6), 467–477. doi:10.1016/j.jana.2010.03.003
   PubMed Web of Science ®Google Scholar
• Mueller, K. J., Patil, K., & Boilesen, E. (1998). The role of uninsurance and race in healthcare utilization by rural minorities. Health Services Research, 33(3 Pt 1), 597–610.
   PubMed Web of Science ®Google Scholar
• Ocfemia, M., Oster, A., Valverde, E., Yungfeng, T., Beer, L., Hernandez, A., & Weiser, J. (2016). HIV drug resistance testing among patients new to HIV care in the United States. Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts.
   Google Scholar
• Office of Management and Budget. (2010). Standards for defining metropolitan and micropolitan statistical areas. Federal Register, 75(123), 37246–39052. http://go.usa.gov/vSpG
   Google Scholar
• Palella Jr, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., … Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. New England Journal of Medicine, 338(13), 853–860. doi:10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Reschovsky, J. D., & Staiti, A. B. (2005). Access and quality: Does rural America lag behind? Health Affairs, 24(4), 1128–1139. doi:10.1377/hlthaff.24.4.1128
   PubMed Web of Science ®Google Scholar
• Ross, L., Lim, M. L., Liao, Q., Wine, B., Rodriguez, A. E., Weinberg, W., & Shaefer, M. (2007). Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naive HIV-infected individuals from 40 United States cities. HIV Clinical Trials, 8(1), 1–8. doi:10.1310/hct0801-1
   PubMed Web of Science ®Google Scholar
• Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid overdose deaths - United States, 2000–2014. MMWR. Morbidity and Mortality Weekly Report, 64(50–51), 1378–1382. doi: 10.15585/mmwr.mm6450a3
   PubMed Web of Science ®Google Scholar
• Spiller, M. W., Broz, D., Wejnert, C., Nerlander, L., & Paz-Bailey, G. (2015). HIV infection and HIV-associated behaviors among persons who inject drugs–20 cities, United States, 2012. MMWR. Morbidity and Mortality Weekly Report, 64(10), 270–275.
   PubMed Web of Science ®Google Scholar
• Torian, L. V., & Forgione, L. A. (2013). Transmitted antiretroviral drug resistance in New York city, 2006–2010: The first five years of routine genotype surveillance. JAIDS Journal of Acquired Immune Deficiency Syndromes, 63(3), e119–e122. doi:10.1097/QAI.0b013e31828d2fc1
   PubMed Web of Science ®Google Scholar
• Weinstock, H. S., Zaidi, I., Heneine, W., Bennett, D., Garcia-Lerma, J. G., Douglas Jr, J. M., … Kaplan, J. E. (2004). The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. The Journal of Infectious Diseases, 189(12), 2174–2180. doi:10.1086/420789
   PubMed Web of Science ®Google Scholar
• Wheeler, W. H., Ziebell, R. A., Zabina, H., Pieniazek, D., Prejean, J., Bodnar, U. R., … Variant, Atypical, and Resistant HIV Surveillance Group. (2010). Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS (London, England), 24(8), 1203–1212. doi:10.1097/QAD.0b013e3283388742 doi: 10.1097/QAD.0b013e3283388742
   PubMed Web of Science ®Google Scholar
• Yanik, E. L., Napravnik, S., Hurt, C. B., Dennis, A., Quinlivan, E. B., Sebastian, J., … Eron, J. J. (2012). Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 61(2), 258–262. doi:10.1097/QAI.0b013e3182618f05
   PubMed Web of Science ®Google Scholar
• Zibbell, J. E., Iqbal, K., Patel, R. C., Suryaprasad, A., Sanders, K. J., Moore-Moravian, L. Holtzman, D. (2015). Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. MMWR. Morbidity and Mortality Weekly Report, 64(17), 453–458.
   PubMed Web of Science ®Google Scholar